Antenatal depression, psychotropic medication use, and inflammation among pregnant women
Archives of Women's Mental Health Jun 10, 2018
Miller ES, et al. - In this cross-sectional secondary analysis of a prospective multicenter observational study, the association between psychotropic medication and inflammatory biomarkers was investigated in 723 pregnant women who underwent a depression screen using the Center for Epidemiologic Studies Depression Scale (CES-D) between 12 and 21 weeks gestation. Compared to pregnant women not responsive to medication or women with untreated antenatal depressive symptoms (ADS), women on pharmacotherapy who respond to treatment for ADS showed lower TNFα. Findings suggest the possibility that either the modulation of the immune system accompanied the therapeutic response in the context of pharmacotherapy or that there may be an association of pre-existing higher levels of TNFα with a poorer response to traditional pharmacotherapy.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries